|
Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …
MarketWatch Celator Pharmaceuticals, Inc. CPXX, -4.33% a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … |
